23. SYSTEMATIC REVIEW OF THE COST - EFFECTIVENESS OF PEMBROLIZUMAB IN RECURRENT OR METASTATIC CERVICAL CANCER. Vietnam Journal of Community Medicine, v. 66, n. CĐ8-NCKH, 22 Aug.2025.